Home

törvény présel Plenáris ülés vaxart azioni forum Hozzájáruló jön Megkeményedik

Bioengineering | Free Full-Text | COVID-19 Vaccines: An Updated Overview of  Different Platforms
Bioengineering | Free Full-Text | COVID-19 Vaccines: An Updated Overview of Different Platforms

Vaxart: A Unique Vaccine Concern (NASDAQ:VXRT) | Seeking Alpha
Vaxart: A Unique Vaccine Concern (NASDAQ:VXRT) | Seeking Alpha

Articles with Vaxart, Inc.
Articles with Vaxart, Inc.

Articles with Vaxart, Inc.
Articles with Vaxart, Inc.

Vaxart (VXRT): Great Potential But Issues Remain | Seeking Alpha
Vaxart (VXRT): Great Potential But Issues Remain | Seeking Alpha

Vaxart stock rises as COVID pill vaccine shows response, safety in trial |  Seeking Alpha
Vaxart stock rises as COVID pill vaccine shows response, safety in trial | Seeking Alpha

COVID-19 Vaccines: Global Health Issues
COVID-19 Vaccines: Global Health Issues

Vaxart, Inc. – SEC Filing
Vaxart, Inc. – SEC Filing

COVID-19 tracker: Omicron booster nods expected Wednesday
COVID-19 tracker: Omicron booster nods expected Wednesday

COVID-19 vaccines: where we stand and challenges ahead | Cell Death &  Differentiation
COVID-19 vaccines: where we stand and challenges ahead | Cell Death & Differentiation

avir20170630_10k.htm
avir20170630_10k.htm

March 2020 – BioHealth Capital Region
March 2020 – BioHealth Capital Region

Vaxart appoints first general counsel | Corporate Secretary
Vaxart appoints first general counsel | Corporate Secretary

Vaccines | Free Full-Text | Drop the Needle; A Temperature Stable Oral  Tablet Vaccine Is Protective against Respiratory Viral Pathogens
Vaccines | Free Full-Text | Drop the Needle; A Temperature Stable Oral Tablet Vaccine Is Protective against Respiratory Viral Pathogens

Webinar: The Quest for a COVID-19 Vaccine | The New York Academy of Sciences
Webinar: The Quest for a COVID-19 Vaccine | The New York Academy of Sciences

Prevention of host-to-host transmission by SARS-CoV-2 vaccines - The Lancet  Infectious Diseases
Prevention of host-to-host transmission by SARS-CoV-2 vaccines - The Lancet Infectious Diseases

Vaxart to Present at the SVB Leerink CybeRx Series: Vaccine Forum
Vaxart to Present at the SVB Leerink CybeRx Series: Vaccine Forum

Vaxart, Inc. – SEC Filing
Vaxart, Inc. – SEC Filing

The next generation Covid-19 vaccines seeking a slice of the market |  Financial Times
The next generation Covid-19 vaccines seeking a slice of the market | Financial Times

Vaxart, Inc. – SEC Filing
Vaxart, Inc. – SEC Filing